Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DHER34.SA
BuyDanaher Corporation · Healthcare · United States · $151.9B · Avg Vol: $13K/d
76
StockRankGet insider-trade alerts
Q
56
V
42
M
72
P/E (TTM)
38.7x
ROE
7.6%
D/E
0.5x
Dividend %
0.5%
COMPANY DESCRIPTION
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 138.7B | 124.4B | 124.3B | 127.9B | -2.7% | 130.7B | 137.1B | 148.2B | 7.6% |
| EPS (BRL) | 0.07 | 0.04 | 0.04 | 0.03 | -20.5% | — | — | — | — |
| Shares | 19.7B | 19.7B | 19.7B | 19.7B | 0.0% | 19.7B | — | — | — |
| Debt | 107.3B | 101.7B | 89.3B | 102.5B | -1.5% | 145.0B | — | — | — |
| Equity | 260.7B | 278.4B | 257.9B | 273.5B | 1.6% | — | — | — | — |
| Op CF | 44.3B | 37.3B | 34.8B | 33.4B | -9.0% | 34.5B | — | — | — |
| Inv CF | -11.6B | -36.9B | -10.3B | -6.2B | — | — | — | — | — |
| Fin CF | -13.4B | -1.4B | -43.7B | -15.4B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+9.5%
SMA 50SMA 200
Close
$7.71
RSI (14)
68.2
52W High
$8.82
From 52W High
0.9%
SCORE BREAKDOWN
Quality
56
ROIC
6.6%62.3
ROE
7.6%64.9
GP/Assets
17.7%41.5
Op. Margin
19.8%81.5
FCF/Assets
6.5%75.0
Piotroski
550.0
Int. Cover
17.3x70.0
D/E Ratio
0.53x29.5
Current Ratio
1.65x31.5
Value
42
P/E (TTM)
38.7x28.0
EV/EBITDA
19.9x32.4
P/FCF
27.8x47.7
P/B
0.6x94.9
P/S
6.1x37.4
Div Yield
0.5%10.0
Momentum
72
52W High %
87%77.8
RS 6M
13%75.1
SMA 50/200
0.97x52.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
57%75.9
FUNDAMENTALS
Market Cap
$151.9B
P/E (Forward)
—
Gross Margin
58.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DHER34.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DHER34.SA | Danaher Corporation(you) | $151.9B | 76 | Buy |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $229.1B | 79 | Buy |
| 603259.SS | WuXi AppTec Co., Ltd. | $69.9B | 80 | Strong Buy |
| IQV | IQVIA Holdings Inc. | $43.1B | 78 | Buy |
| IDXX.MX | IDEXX Laboratories, Inc. | $43.9B | 73 | Buy |
| A | Agilent Technologies, Inc. | $43.4B | 73 | Buy |
| ILMN | Illumina, Inc. | $32.6B | 78 | Buy |
| LONN.SW | Lonza Group AG | $50.4B | 61 | Hold |
| WAT | Waters Corporation | $40.7B | 63 | Hold |
| NTRA | Natera, Inc. | $47.0B | 56 | Hold |
Peer medians: ROE 2.0% · P/E 24.1x · Gross margin 52.5%